VANCOUVER, July 25, 2019 /PRNewswire/ – Correvio Pharma Corp. (CORV) (CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that the U.S. Food and Drug Administration (FDA) has accepted for…Original Article
FDA Accepts Correvio’s Resubmitted New Drug Application for Brinavess (vernakalant)
